Krish Patel
Director, Hematologic Malignancies and Cellular Therapy at Swedish Cancer Institute- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Seattle, Washington, United States, US
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Credentials
-
Hematology
American Board of Internal MedicineOct, 2017- Nov, 2024 -
Medical Oncology
American Board of Internal MedicineOct, 2016- Nov, 2024 -
ABIM Internal Medicine
-
Experience
-
Swedish Cancer Institute
-
United States
-
Hospitals and Health Care
-
1 - 100 Employee
-
Director, Hematologic Malignancies and Cellular Therapy
-
Jan 2022 - Present
-
-
Director of Lymphoma Program
-
Apr 2019 - Present
-
-
Physician/Clinical Investigator, Hematologic Malignancies and Cellular Therapy
-
Jul 2016 - Present
Lymphoma physician and clinical investigator at Center for Blood Disorders and Stem Cell Transplantation.
-
-
-
Duke University Medical Center
-
Hospitals and Health Care
-
700 & Above Employee
-
Hematology/Oncology Fellow
-
Jul 2012 - Jun 2016
-
-
Chief Resident, Internal Medicine
-
Jul 2013 - Jun 2014
-
-
-
Duke University Health System
-
Hospitals and Health Care
-
700 & Above Employee
-
Resident Physician - Internal Medicine
-
Jun 2009 - Jun 2012
-
-
-
The National Institutes of Health
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
CRTP Fellow
-
Aug 2007 - Aug 2008
Research Fellow in the Gius Lab at the NCI/NIH. Elaborated a novel model relating cellular aging and mitochondrial dysfunction to oncogenesis. Research Fellow in the Gius Lab at the NCI/NIH. Elaborated a novel model relating cellular aging and mitochondrial dysfunction to oncogenesis.
-
-
Education
-
Duke University School of Medicine
MD -
Duke University
B.S., Biology, Pharmacology
Community
You need to have a working account to view this content.
Click here to join now